LIACFLASH: a life changing IOeRT technology for oncology carebroad
LIAC FLASH · Horizon Europe grant · 2022-12-01–2025-05-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2022-ACCELERATOR-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2022-ACCELERATOROPEN-01. CORDIS record →
Objective
Radiation Therapy is, along with surgery, the most effective therapeutic approach for the treatment of solid tumours. Unfortunately, biological effects of radiation dose to healthy organs at risk (often surrounding targeted tumour mass) represent a major dose-limiting constraint in Radiation Therapy. This implies that tumours cannot be always successfully treated, as delivered dose might not be enough for an effective treatment, decreasing survival of these cancer patients. LIACFLASH is an IOeRT system for cancer treatment built on a breakthrough scientific discovery: the FLASH effect, which enables delivery of high radiation dose with significantly reduced associated radiocytotoxicity, while achieving efficient tumour killing, widening the therapeutic window.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| S.I.T. - SORDINA IORT TECHNOLOGIES SPA | IT | coordinator | €2,499,962 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.